A Single-Dose Study of the Safety and Tolerability of REGN475(SAR164877) in Healthy Subjects
Clinical trial NCT00856310 · COMPLETED
Trial details
- NCT number
- NCT00856310
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2009-11-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.